BRPI0406580A - Uso de carbamato de (s)-n-etil-n-metil-3-[1-(dimetilamino)etil]-fenil, uso de um ou mais ingredientes ativos e medicamento para a profilaxia de envenenamento por inibidores de colinesterase - Google Patents
Uso de carbamato de (s)-n-etil-n-metil-3-[1-(dimetilamino)etil]-fenil, uso de um ou mais ingredientes ativos e medicamento para a profilaxia de envenenamento por inibidores de colinesteraseInfo
- Publication number
- BRPI0406580A BRPI0406580A BR0406580-8A BRPI0406580A BRPI0406580A BR PI0406580 A BRPI0406580 A BR PI0406580A BR PI0406580 A BRPI0406580 A BR PI0406580A BR PI0406580 A BRPI0406580 A BR PI0406580A
- Authority
- BR
- Brazil
- Prior art keywords
- ethyl
- dimethylamino
- methyl
- poisoning
- active ingredients
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 title abstract 3
- 239000000544 cholinesterase inhibitor Substances 0.000 title abstract 3
- 231100000572 poisoning Toxicity 0.000 title abstract 3
- 230000000607 poisoning effect Effects 0.000 title abstract 3
- 229940122041 Cholinesterase inhibitor Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
- LLMITOZMSCEYMQ-UHFFFAOYSA-N 1-(dimethylamino)ethyl carbamate Chemical compound CN(C)C(C)OC(N)=O LLMITOZMSCEYMQ-UHFFFAOYSA-N 0.000 abstract 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10301851A DE10301851A1 (de) | 2003-01-17 | 2003-01-17 | Verfahren zur medikamentösen Prophylaxe gegen Vergiftungen durch Cholinesterase-Hemmer, sowie hierfür geeignete Wirkstoffe und Arzneimittel |
| PCT/EP2004/000289 WO2004064829A1 (de) | 2003-01-17 | 2004-01-16 | Verfahren zur medikamentösen prophylaxe gegen vergiftungen durch cholinesterase-hemmer, sowie hierfür geeignete wirkstoffe und arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0406580A true BRPI0406580A (pt) | 2005-12-20 |
Family
ID=32602728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0406580-8A BRPI0406580A (pt) | 2003-01-17 | 2004-01-16 | Uso de carbamato de (s)-n-etil-n-metil-3-[1-(dimetilamino)etil]-fenil, uso de um ou mais ingredientes ativos e medicamento para a profilaxia de envenenamento por inibidores de colinesterase |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20060183796A1 (https=) |
| EP (1) | EP1585514A1 (https=) |
| JP (1) | JP2006516267A (https=) |
| KR (1) | KR20050104347A (https=) |
| CN (1) | CN1741800A (https=) |
| BR (1) | BRPI0406580A (https=) |
| DE (1) | DE10301851A1 (https=) |
| IL (1) | IL169687A0 (https=) |
| WO (1) | WO2004064829A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2936150B1 (fr) * | 2008-09-19 | 2013-09-06 | Dermathologiques D Uriage Lab | Nouvelles compositions dermatologiques protectrices de la peau et des muqueuses |
| GB0809905D0 (en) * | 2008-06-02 | 2008-07-09 | Secr Defence | A Transdermal drug delivery device |
| CN115989025A (zh) * | 2020-08-31 | 2023-04-18 | 耐贝医药株式会社 | 用于缓解或治疗神经退行性疾病的症状的贴剂 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL74497A (en) * | 1985-03-05 | 1990-02-09 | Proterra Ag | Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives |
| ES2201050T3 (es) * | 1991-09-26 | 2004-03-16 | The Government Of The Usa As Represented By The Secretary Of Department Of Health And Human Services | Compuestos que presentan una inhibicion selectiva de la acteil-colinesterasa. |
| DE4342174C1 (de) * | 1993-12-10 | 1995-05-11 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System sowie ein Verfahren zur Herstellung eines transdermalen therapeutischen Systems zur kombinierten transdermalen Anwendung von Physostigmin und Scopolamin für die Prophylaxe und zur Vorbehandlung einer Vergiftung durch hochtoxische phosphororganische Nervengifte, insbesondere Soman und seine Verwendung |
| DE4342173A1 (de) * | 1993-12-10 | 1995-06-14 | Lohmann Therapie Syst Lts | Pharmazeutische Formulierung zur Prophylaxe bzw. Vorbehandlung einer Vergiftung durch phosphororganische Cholinesterasehemmer |
| US5807671A (en) * | 1995-01-09 | 1998-09-15 | Yissum Research Development Company Of Hebrew University Of Jerusalem | Method of screening for genetic predisposition to anticholinesterase therapy |
| US6955819B2 (en) * | 1998-09-29 | 2005-10-18 | Zars, Inc. | Methods and apparatus for using controlled heat to regulate transdermal and controlled release delivery of fentanyl, other analgesics, and other medical substances |
| JP4422342B2 (ja) * | 1998-11-27 | 2010-02-24 | ザノヒェミア・ファルマツォイティカ・アー・ゲー | せん妄の治療へのコリン作動性中枢神経系エフェクターの使用 |
| US6756385B2 (en) * | 2000-07-31 | 2004-06-29 | Pfizer Inc. | Imidazole derivatives |
-
2003
- 2003-01-17 DE DE10301851A patent/DE10301851A1/de not_active Withdrawn
-
2004
- 2004-01-16 WO PCT/EP2004/000289 patent/WO2004064829A1/de not_active Ceased
- 2004-01-16 US US10/542,515 patent/US20060183796A1/en not_active Abandoned
- 2004-01-16 JP JP2005516402A patent/JP2006516267A/ja active Pending
- 2004-01-16 KR KR1020057012992A patent/KR20050104347A/ko not_active Ceased
- 2004-01-16 EP EP04702672A patent/EP1585514A1/de not_active Withdrawn
- 2004-01-16 BR BR0406580-8A patent/BRPI0406580A/pt not_active IP Right Cessation
- 2004-01-16 CN CNA2004800024123A patent/CN1741800A/zh active Pending
-
2005
- 2005-07-14 IL IL169687A patent/IL169687A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004064829A1 (de) | 2004-08-05 |
| IL169687A0 (en) | 2007-07-04 |
| DE10301851A1 (de) | 2004-07-29 |
| JP2006516267A (ja) | 2006-06-29 |
| CN1741800A (zh) | 2006-03-01 |
| US20060183796A1 (en) | 2006-08-17 |
| KR20050104347A (ko) | 2005-11-02 |
| EP1585514A1 (de) | 2005-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE293995T1 (de) | Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten | |
| HRP20040996B1 (hr) | Tablete visokog sadržaja lijeka | |
| BR0212042A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto | |
| PL369108A1 (en) | 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
| MY141243A (en) | Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus | |
| BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
| DK0750618T3 (da) | Oxazolidinonderivater og farmaceutiske præparater indeholdende dem | |
| BR9909565A (pt) | Derivados bicìclicos do ácido hidroxâmico | |
| PT1506185E (pt) | Compostos novos e sua utilizacao | |
| MXPA05007609A (es) | Antagonista de un receptor sensible al calcio. | |
| NO20051695L (no) | Nye spirokondenserte kinazolinoner og deres anvendelse som fosfodiestereaseinbibitorer | |
| ECSP055701A (es) | Nuevos derivados de pirimidinamida y el uso de los mismos | |
| BR0212069A (pt) | Agentes antidiabéticos orais | |
| BR0306928A (pt) | Composições farmacêuticas estáveis compreendendo inibidores de enzimas conversoras de angiotensina (ace) | |
| DK1408966T3 (da) | Synergistiske farmaceutiske kombinationer til forebyggelse eller behandling af diabetes | |
| ATE253359T1 (de) | Antithrombotische mittel | |
| DK0673376T3 (da) | Bicykliske pyrimidinforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som omfatter dem | |
| WO2006042478A8 (fr) | Inhibiteurs de petites molecules de la protease principale des coronavirus, leur preparation et utilisation | |
| BRPI0406580A (pt) | Uso de carbamato de (s)-n-etil-n-metil-3-[1-(dimetilamino)etil]-fenil, uso de um ou mais ingredientes ativos e medicamento para a profilaxia de envenenamento por inibidores de colinesterase | |
| EP1325903A4 (en) | DERIVATIVES OF 2,3-DIPHENYLPROPIONIC ACID OR THEIR SALTS, MEDICAMENTS OR INHIBITORS OF CELL ADHESION CONTAINING THE SAME, AND THEIR USE | |
| IT1317049B1 (it) | Composti utili per la preparazione di medicamenti ad attivita'inibitrice della fosfodiesterasi iv. | |
| DE69828522D1 (de) | Antithrombotische mittel | |
| PT1411956E (pt) | Utilizacao de polissacaridos sobre-sulfatados como inibidores de vih | |
| NO20055254L (no) | Farmasoytisk kombinasjon for behandling av spastisitet og/eller smerte | |
| BRPI0513549A (pt) | composições farmacêuticas para o tratamento de leishmaniose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012. |